Lini Subin, senior manager, regulatory affairs, ELC Group, discusses how EMA opens doors for global biosimilar development
The biosimilar regulatory framework in Europe is the most advanced in the world. The European Medicines Agency (EMA) has now taken initiatives that will lead to the global development of biosimilar drugs.